DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
LinksClose Window
References
Wakabayashi H, Inaki A, Yoshimura K. et al.
A phase I clinical trial for [(131)I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma.
Sci Rep 2019;
9: 7625
DOI: 10.1038/s41598-019-43880-6. (PMID: 31110198)
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.